Northern Trust Corp increased its stake in shares of Cadre Holdings, Inc. (NYSE:CDRE - Free Report) by 38.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 300,105 shares of the company's stock after purchasing an additional 83,903 shares during the quarter. Northern Trust Corp owned approximately 0.74% of Cadre worth $9,693,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in the stock. Barclays PLC increased its holdings in shares of Cadre by 335.6% in the third quarter. Barclays PLC now owns 53,397 shares of the company's stock valued at $2,025,000 after purchasing an additional 41,139 shares during the period. Hennion & Walsh Asset Management Inc. increased its holdings in shares of Cadre by 29.1% in the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 25,003 shares of the company's stock valued at $808,000 after purchasing an additional 5,639 shares during the period. SG Americas Securities LLC acquired a new position in shares of Cadre in the fourth quarter valued at about $100,000. Harel Insurance Investments & Financial Services Ltd. increased its holdings in shares of Cadre by 51.9% in the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 3,066 shares of the company's stock valued at $99,000 after purchasing an additional 1,048 shares during the period. Finally, WCM Investment Management LLC acquired a new position in shares of Cadre in the fourth quarter valued at about $12,420,000. 43.95% of the stock is currently owned by hedge funds and other institutional investors.
Cadre Stock Performance
Shares of CDRE stock traded down $0.44 during mid-day trading on Friday, reaching $32.69. The stock had a trading volume of 298,299 shares, compared to its average volume of 250,426. The business's fifty day moving average is $31.31 and its 200-day moving average is $33.46. The company has a current ratio of 3.01, a quick ratio of 1.96 and a debt-to-equity ratio of 0.65. The firm has a market cap of $1.33 billion, a price-to-earnings ratio of 39.39, a PEG ratio of 1.58 and a beta of 1.34. Cadre Holdings, Inc. has a 1-year low of $27.07 and a 1-year high of $40.28.
Cadre (NYSE:CDRE - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.13 by $0.10. The business had revenue of $130.11 million for the quarter, compared to analyst estimates of $121.53 million. Cadre had a return on equity of 12.88% and a net margin of 6.34%. The company's revenue was down 5.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.18 earnings per share. On average, research analysts forecast that Cadre Holdings, Inc. will post 1.05 earnings per share for the current year.
Cadre Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, May 16th. Investors of record on Friday, May 2nd were issued a dividend of $0.095 per share. This represents a $0.38 annualized dividend and a yield of 1.16%. The ex-dividend date of this dividend was Friday, May 2nd. Cadre's dividend payout ratio (DPR) is 40.00%.
Insider Buying and Selling
In related news, CEO Warren B. Kanders sold 50,000 shares of the firm's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $31.88, for a total transaction of $1,594,000.00. Following the sale, the chief executive officer now directly owns 10,866,192 shares of the company's stock, valued at $346,414,200.96. This trade represents a 0.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 37.00% of the stock is owned by corporate insiders.
Cadre Company Profile
(
Free Report)
Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.
Featured Articles

Before you consider Cadre, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cadre wasn't on the list.
While Cadre currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.